July 05, 2009 06:00 PM Eastern Time
BUSINESS WIRE
Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis
Tweet
View Full Size
Download
Thumbnail
JPEG
,
72
x
14
,
15.7 KB
Preview
JPEG
,
144
x
27
,
18.0 KB
Small
JPEG
,
300
x
57
,
24.8 KB
Full Size
JPEG
,
1379
x
260
,
67.7 KB
Smart Multimedia Gallery
View and Share Logo
Download Small
Download Full Size
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
All News
|
News with Multimedia
>
News Release: Alcon Commences Phase 2 Clinical Trial of NovaB...
Get Business Wire News on Your Website
Terms of Use
|
©2012 Business Wire
Better Be Business Wired.
Business Wire
is the leading source for
press releases
, photos, multimedia and
regulatory filings
from companies and groups throughout the world.